SCHEMBL7316444

SCHEMBL7316444

COc1ccc(-c2ccsc2C2(O)c3ccccc3-c3ccccc32)cc1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ PDK2 Q15119 5/20 0.47
▸ ABL1 P00519 2/20 0.43
▸ ABCB1 P08183 2/20 0.43
▸ BCR P11274 2/20 0.43
▸ HDAC4 P56524 1/20 0.42
▸ HDAC2 Q92769 1/20 0.42
▸ HDAC8 Q9BY41 1/20 0.42
▸ PTGS2 P35354 1/20 0.40
▸ BACE1 P56817 2/20 0.39
▸ GAA P10253 2/20 0.38
▸ POLB P06746 1/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ LMNA P02545 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ AR P10275 1/20 0.37
▸ ACACA Q13085 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7313758 0.84 THRB (0.43) PDK2HDAC4HDAC2HDAC8PTGS2
SCHEMBL7319520 0.81 PDK2 (0.44) PDK2PTGS2
SCHEMBL27619850 0.75 PDK2 (0.47) PDK2MEN1KMT2AMAPT
SCHEMBL7315127 0.74 PDK2 (0.51) PDK2ABL1ABCB1BCRHDAC4
SCHEMBL7322385 0.73 HDAC4 (0.37) PDK2HDAC4HDAC2HDAC8PTGS2
SCHEMBL7322395 0.73 HDAC4 (0.37) PDK2HDAC4HDAC2HDAC8PTGS2
SCHEMBL7316883 0.72 OPRM1 (0.41) PDK2GAAPOLBMEN1KMT2A
SCHEMBL7316321 0.71 THRB (0.39) PDK2MEN1KMT2ALMNAMAPT
SCHEMBL7316576 0.69 CYP2D6 (0.41) PDK2KMT2AMAPT
SCHEMBL12715050 0.69 ABL1 (0.79) ABL1ABCB1BCRHDAC4HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2001009117-A1 TRICYCLIC COMPOUNDS AS GLYCINE TRANSPORT INHIBITORS ALLELLIX NEUROSCIENCE INC. (US) 2001-02-08 — — WO disclosed
US-6162824-A NERVOUS SYSTEM DISORDERS; PSYCHOLOGICAL DISORDERS ALLELIX NEUROSCIENCE INC. 2000-12-19 — — US disclosed
Send feedback